Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
CEO Crisis Action Plan: Next 48 Hours Guiding Principles: Patient safety first. Regulatory compliance is non-negotiable. Transparency protects long-term enterprise value. Delaying disclosure of a serious, unexpected adverse event increases legal, financial, and reputational risk exponentially.Read the full answer